Gates Foundation Trust’s Johnson & Johnson JNJ Stock Holding History

Gates Foundation Trust’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,945	Closed	-$2.33M	–	47
2023 Q3	$2.33M	Buy	+14,945	New	+$2.47M	0.01%	54

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gates Foundation Trust's JNJ Position: Q4 2023 in Review

Gates Foundation Trust sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 14,945 shares — an estimated $2.33M sold.

Gates Foundation Trust first reported a position in JNJ in Q3 2023 and held it in 1 quarter. The position peaked at $2.33M in Q3 2023. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

Gates Foundation Trust reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
Gates Foundation Trust sold 14,945 Johnson & Johnson shares in Q4 2023, an estimated $2.33M.
Gates Foundation Trust first reported a position in Johnson & Johnson in Q3 2023 and held it in 1 quarter.
Gates Foundation Trust's Johnson & Johnson position peaked at $2.33M in Q3 2023.
3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.